Vitamin D valuable supplement for improving glycemic control in diabetes patients
Afghanistan: According to a study published in BMC Endocrine Disorders, Vitamin D supplementation might reduce FPG, HbA1c, and HOMA-IR in type 2 diabetes patients with low vitamin D status.Vitamin D has potential extra skeletal outcomes in diabetes and many other diseases. Some hypotheses state its anti-diabetic properties while it may have an essential role in glucose homeostasis.The...
Afghanistan: According to a study published in BMC Endocrine Disorders, Vitamin D supplementation might reduce FPG, HbA1c, and HOMA-IR in type 2 diabetes patients with low vitamin D status.
Vitamin D has potential extra skeletal outcomes in diabetes and many other diseases. Some hypotheses state its anti-diabetic properties while it may have an essential role in glucose homeostasis.
The question is, Is there any role of Vitamin D in people with diabetes for glycemic control? The evidence remains conflicting in this context.
Mohammad Ashraf Farahmand and colleagues from Tehran University of Medical Sciences have assessed the role of Vitamin D supplementation in type 2 diabetes (T2D) patients. The indicators of glycemic control were fasting plasma glucose (FPG), HbA1c, and homeostasis model assessment insulin resistance (HOMA-IR).
The researchers collected data from electronic databases like PubMed/Medline, Web of Science, Embase, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and NIH’s Clinical Trials Registry.
The study summary includes the following:
- The study included a meta-analysis having 46 RCTs.
- The RCTs had 2164 intervention subjects and 2149 placebo controls.
- There was a significant change in pooled analyses for HbA1c between the two groups. The weighted mean difference (WMD) was -0.20%.
- After Analysing Fasting Plasma Glucose, a significant reduction was noted in the intervention group with WMD of -5.02 mg/dl after Vitamin D supplementation.
- Pooled analysis results for HOMA-IR revealed a significant change between the two groups with -0.42.
- As shown in subgroup analyses, the most efficacy was in a higher dose, short intervention period and in patients who had a deficiency of vitamin D.
To conclude, Vitamin D supplementation is beneficial for T2D patients because it reduces FPG, HbA1c, and HOMA-IR in patients with deficient vitamin D status.
The researchers added that the effect is prominent when vitamin D is given in large doses and for a short time.
Further reading:
Farahmand, M.A., Daneshzad, E., Fung, T.T. et al. What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord 23, 15 (2023). https://doi.org/10.1186/s12902-022-01209-x
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd